Skip to Content

Proton Therapy for Testicular Cancer

Download Fact Sheet

Overview

Testicular cancer is one of the most treatable and survivable types of cancer if detected early. Testicular cancer occurs when cells of one or both testicles become cancerous. A disease most often associated with young men, testicular cancer is often diagnosed in men ages 20 to 34. The disease is essentially unpreventable as most risk factors are present at birth, and men with no risk factors can also be diagnosed with testicular cancer. However, if detected and treated in early stages when the cancer is only in the testicle, testicular cancer patients have a 99 percent chance of survival after five years. Most cases of testicular cancer are initially identified by the patient, making self-observation critical to early detection.

 

Benefits of Proton Therapy

  • High-energy, precisely-targeted proton beams can deliver high doses of radiation to destroy cancerous cells, reducing recurrence rates for many cancer cases.
  • Proton therapy is non-invasive and may reduce side effects.
  • Patients treated with proton therapy may have increased tolerance for chemotherapy.
  • Patients can maintain their current quality of life during and after treatment.
  • It is sometimes used effectively to treat areas that have already been treated with radiation.

Sources: American Cancer Society, American Society of Clinical Oncology, American Society of Colon and Rectal Surgeons, Centers for Disease Control and Prevention, and National Cancer Institute